Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis

Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis - ScienceDirect

Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: a systematic review and meta-analysis, European Journal of Medical Research

Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study - The Lancet Healthy Longevity

Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study - eClinicalMedicine

Pathogens, Free Full-Text

COVID-19 vaccines for patients with cancer: benefits likely outweigh risks, Journal of Hematology & Oncology

Cancers, Free Full-Text

Immunogenicity of clinically relevant SARS-CoV-2 vaccines in nonhuman primates and humans

Vaccines, Free Full-Text